Multifrequency Tympanometry Could Aid Diagnosis of Meniere Disease
By Lori Solomon HealthDay Reporter
MONDAY, May 6, 2024 -- Multifrequency tympanometry (MFT) could aid the diagnosis of Meniere disease (MD), according to a review published online March 4 in the Journal of Clinical Medicine.
Christos Tsilivigkos, from the National and Kapodistrian University of Athens in Greece, and colleagues conducted a systematic literature review and meta-analysis to examine the role of MFT in the diagnosis of MD. The analysis included seven identified studies that directly compared ears affected by MD to unaffected or control ears.
The researchers found that among 282 ears affected by MD, 197 unaffected ears in patients with MD, and 420 ears in healthy controls, there were no statistically significant differences between the groups for resonant frequency. In affected ears, the pure tone audiometry average of the lower frequencies was significantly greater than that seen in unaffected ears. For a conductance tympanogram at 2 kHz, there was statistically significantly greater G width of 2 kHz observed in the affected ears versus either unaffected or control ears. Control ears had a statistically significant lesser G width of 2 kHz compared with the other two groups.
"MFT, and specifically G width at 2 kHz, could be an important tool in the diagnosis of MD," the authors write. "Further studies should be conducted to clarify the definitive role of MFT in MD, the mechanism that underlies these measurements, and the diagnostic accuracy of this test."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
High Level of Approval Observed for Polygenic Embryo Screening
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...
AI Chatbots Can Generate Quality, Empathetic, Readable Responses
FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...
Slight Decline Seen in U.S. Drug Overdose Deaths
THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.